• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BGL:GR

19.114 EUR 0.251 1.30%

As of 02:08:19 ET on 09/19/2014.

Snapshot for BioGaia AB (BGL)

Open: 18.655 Day's Range: 18.655 - 19.155 Volume: 0
Previous Close: 19.365 52wk Range: 18.032 - 28.256 1-Yr Rtn: -31.60%

Stock Chart for BGL

No chart data available.
  • BGL:GR 19.114
  • 1D
  • 1M
  • 1Y
19.365
Interactive BGL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BGL

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 37.9902
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) 4.6200
Est. PEG Ratio -
Market Cap (M EUR) 327.15
Shares Outstanding (M) 16.53
30 Day Average Volume 6
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.94%
Cash Dividend (SEK) 3.3500
Dividend Ex-Date 05/07/2014
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BGL

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for BGL

BioGaia AB develops and markets health care products. The Company sells foods with healthy additives that help increase resistance against illnesses, and nutritional products with therapeutic effects for adults and children. BioGaia also sells animal feeds and performs pharmaceutical research in the United States and Sweden. Many products are sold worldwide by license.

Peter RothschildPresident/FounderMargareta HagmanExec VP:Acctg & IR
Urban StrindlovExec VP:Partner & Product DevEamonn ConnollySenior VP:Research
More Company Profile & Key Executives for BGL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil